Company Filing History:
12 out of 1,866 
4 out of 10 
1 out of 4 Years Active: 2019-2025
Title: Riccardo Lucca Gottardi: Innovator in Bioreactor Technology
Introduction
Riccardo Lucca Gottardi is a prominent inventor based in Pittsburgh, PA, known for his significant contributions to bioreactor technology. With a total of 12 patents to his name, Gottardi has made remarkable advancements in the field of tissue culture and autoimmune disease treatment.
Latest Patents
Gottardi's latest patents include a "Modular, microfluidic, mechanically active bioreactor for 3D, multi-tissue, tissue culture." This invention discloses various bioreactor devices and systems designed for growing cellular material. The system can include a well plate with multiple wells, each containing a bioreactor. Additionally, the bioreactor features an inner body that divides it into distinct chambers, facilitating the growth of multi-tissue samples. Another notable patent is for "Autoimmune disease treatment with chemokine-loaded alginate microparticles." This invention provides microparticles that induce the migration of multipotent stem cells to specific anatomical sites, demonstrating various release profiles based on alginate concentration. These microparticles can be administered locally or through intraarticular injection, proving useful in conditions like osteoarthritis.
Career Highlights
Gottardi has worked with esteemed organizations such as the University of Pittsburgh and Ri.med Foundation. His work has significantly impacted the development of innovative solutions in the medical field, particularly in tissue engineering and regenerative medicine.
Collaborations
Gottardi has collaborated with notable colleagues, including Rocky Sung Chi Tuan and Peter Alexander. Their combined expertise has contributed to the advancement of biotechnological innovations.
Conclusion
Riccardo Lucca Gottardi stands out as a leading inventor in the realm of bioreactor technology, with a focus on enhancing tissue culture and addressing autoimmune diseases. His contributions continue to shape the future of medical research and applications.